Raymond James Financial’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.69M	Buy	455,470 +161,091	+55%	+$598K	﹤0.01%	3210
2025 Q1	$951K	Buy	294,379 +181,475	+161%	+$586K	﹤0.01%	3518
2024 Q4	$629K	Buy	+112,904	New	+$629K	﹤0.01%	3745